表紙:自己免疫疾患診断薬の世界市場 (2022-2030年):市場規模 (疾患タイプ・検査タイプ・エンドユーザー別)・地域的展望・用途の潜在性・市場シェア・予測
市場調査レポート
商品コード
1100651

自己免疫疾患診断薬の世界市場 (2022-2030年):市場規模 (疾患タイプ・検査タイプ・エンドユーザー別)・地域的展望・用途の潜在性・市場シェア・予測

Autoimmune Disease Diagnostics Market Size By Disease Type, By Test Type, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2030

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 190 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
自己免疫疾患診断薬の世界市場 (2022-2030年):市場規模 (疾患タイプ・検査タイプ・エンドユーザー別)・地域的展望・用途の潜在性・市場シェア・予測
出版日: 2022年07月07日
発行: Global Market Insights Inc.
ページ情報: 英文 190 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

自己免疫疾患診断薬の市場は、自己免疫疾患の有病率の世界的上昇から、2030年にかけて大きく成長すると予測されています。

また、診断分野の技術的進歩やR&D活動に対する政府の支援的な取り組みも予測期間中の市場成長に弾みをつけると推測されています。

疾患タイプ別では、関節リウマチ、全身性エリテマトーデス (SLE) 、乾癬などの拡大から、これらの疾患の診断ニーズが高まっており、全身性自己免疫疾患の部門が2021年に3億2,700万米ドを超える規模を示しています。また、検査タイプ別では、1型糖尿病、重症筋無力症など、免疫系を標的とした慢性疾患や疾病の発生が増加しており、2021年には、抗核抗体検査の部門が約43%の収益シェアを示しています。

当レポートでは、世界の自己免疫疾患診断薬の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 自己免疫疾患診断薬産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 促進要因
    • 潜在的リスク&課題
  • 成長の可能性
  • COVID-19:影響分析
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 自己免疫疾患診断薬市場:疾患タイプ別

  • 主要動向
  • 全身性自己免疫疾患
    • 関節リウマチ
    • 全身性エリテマトーデス
    • 乾癬
    • 多発性硬化症
    • その他
  • 限局性自己免疫疾患
    • 炎症性腸疾患

第5章 自己免疫疾患診断薬市場:検査タイプ別

  • 主要動向
  • 抗核抗体検査
  • 自己抗体検査
  • C反応性タンパク質 (CRP)
  • 全血球計算 (CBC)
  • 尿検査
  • その他

第6章 自己免疫疾患診断薬市場:エンドユーザー別

  • 主要動向
  • 病院
  • 診断センター
  • その他

第7章 自己免疫疾患診断薬市場:地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • 競合ダッシュボード
  • Abbott Laboratories
  • Bio-rad Laboratories
  • F. Hoffmann-la Roche
  • Thermo Fisher Scientific
  • Myriad Genetics
  • Euroimmun AG(Perkin Elmer)
  • DIAsource ImmunoAssays SA
  • Hemagen Diagnostics
  • Trinity Biotech Plc.
  • SQI Diagnostics Inc.
  • Quest Diagnostics
  • Siemens Healthineers Inc.
図表

Data Tables

  • TABLE 1. Autoimmune disease diagnostics industry 360 degree synopsis, 2017 - 2030
  • TABLE 2. Global autoimmune disease diagnostics market, 2017 - 2021 (USD Million)
  • TABLE 3. Global autoimmune disease diagnostics market, 2022 - 2030 (USD Million)
  • TABLE 4. Global autoimmune disease diagnostics market, by disease type, 2017 - 2021 (USD Million)
  • TABLE 5. Global autoimmune disease diagnostics market, by disease type, 2022 - 2030 (USD Million)
  • TABLE 6. Global autoimmune disease diagnostics market, by test type, 2017 - 2021 (USD Million)
  • TABLE 7. Global autoimmune disease diagnostics market, by test type, 2022 - 2030 (USD Million)
  • TABLE 8. Global autoimmune disease diagnostics market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 9. Global autoimmune disease diagnostics market, by end-use, 2022 - 2030 (USD Million)
  • TABLE 10. Global autoimmune disease diagnostics market, by region, 2017 - 2021 (USD Million)
  • TABLE 11. Global autoimmune disease diagnostics market, by region, 2022 - 2030 (USD Million)
  • TABLE 12. Industry impact forces
  • TABLE 13. Systemic autoimmune disease market size, by region, 2017 - 2021 (USD Million)
  • TABLE 14. Systemic autoimmune disease market size, by region, 2022 - 2030 (USD Million)
  • TABLE 15. Rheumatoid arthritis disease market size, by region, 2017 - 2021 (USD Million)
  • TABLE 16. Rheumatoid arthritis market size, by region, 2022 - 2030 (USD Million)
  • TABLE 17. Systemic lupus erythematosus (SLE) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 18. Systemic Lupus Erythematosus (SLE) market size, by region, 2022 - 2030 (USD Million)
  • TABLE 19. Psoriasis market size, by region, 2017 - 2021 (USD Million)
  • TABLE 20. Psoriasis market size, by region, 2022 - 2030 (USD Million)
  • TABLE 21. Multiple Sclerosis market size, by region, 2017 - 2021 (USD Million)
  • TABLE 22. Multiple Sclerosis market size, by region, 2022 - 2030 (USD Million)
  • TABLE 23. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 24. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 25. Localized autoimmune disease market size, by region, 2017 - 2021 (USD Million)
  • TABLE 26. Localized autoimmune disease market size, by region, 2022 - 2030 (USD Million)
  • TABLE 27. Inflammatory bowel disease market size, by region, 2017 - 2021 (USD Million)
  • TABLE 28. Inflammatory bowel disease market size, by region, 2022 - 2030 (USD Million)
  • TABLE 29. Type 1 diabetes market size, by region, 2017 - 2021 (USD Million)
  • TABLE 30. Type 1 diabetes market size, by region, 2022 - 2030 (USD Million)
  • TABLE 31. Thyroid market size, by region, 2017 - 2021 (USD Million)
  • TABLE 32. Thyroid market size, by region, 2022 - 2030 (USD Million)
  • TABLE 33. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 34. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 35. Antinuclear antibody tests market size, by region, 2017 - 2021 (USD Million)
  • TABLE 36. Antinuclear antibody tests market size, by region, 2022 - 2030 (USD Million)
  • TABLE 37. Autoantibody tests market size, by region, 2017 - 2021 (USD Million)
  • TABLE 38. Autoantibody tests market size, by region, 2022 - 2030 (USD Million)
  • TABLE 39. C-reactive protein (CRP) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 40. C-reactive protein (CRP) market size, by region, 2022 - 2030 (USD Million)
  • TABLE 41. Complete blood count (CBC) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 42. Complete blood count (CBC) market size, by region, 2022 - 2030 (USD Million)
  • TABLE 43. Urinalysis market size, by region, 2017 - 2021 (USD Million)
  • TABLE 44. Urinalysis market size, by region, 2022 - 2030 (USD Million)
  • TABLE 45. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 46. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 47. Hospitals market size, by region, 2017 - 2021 (USD Million)
  • TABLE 48. Hospitals market size, by region, 2022 - 2030 (USD Million)
  • TABLE 49. Diagnostics centers market size, by region, 2017 - 2021 (USD Million)
  • TABLE 50. Diagnostics centers market size, by region, 2022 - 2030 (USD Million)
  • TABLE 51. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 52. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 53. North America autoimmune disease diagnostics market size, by country, 2017 - 2021 (USD Million)
  • TABLE 54. North America autoimmune disease diagnostics market size, by country, 2022 - 2030 (USD Million)
  • TABLE 55. North America autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 56. North America autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 57. North America autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 58. North America autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 59. North America autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 60. North America autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 61. North America autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 62. North America autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 63. North America autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 64. North America autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 65. U.S. autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 66. U.S. autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 67. U.S. autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 68. U.S. autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 69. U.S. autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 70. U.S. autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 71. U.S. autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 72. U.S. autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 73. U.S. autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 74. U.S. autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 75. Canada autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 76. Canada autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 77. Canada autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 78. Canada autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 79. Canada autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 80. Canada autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 81. Canada autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 82. Canada autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 83. Canada autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 84. Canada autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 85. Europe autoimmune disease diagnostics market size, by country, 2017 - 2021 (USD Million)
  • TABLE 86. Europe autoimmune disease diagnostics market size, by country, 2022 - 2030 (USD Million)
  • TABLE 87. Europe autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 88. Europe autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 89. Europe autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 90. Europe autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 91. Europe autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 92. Europe autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 93. Europe autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 94. Europe autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 95. Europe autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 96. Europe autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 97. Germany autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 98. Germany autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 99. Germany autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 100. Germany autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 101. Germany autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 102. Germany autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 103. Germany autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 104. Germany autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 105. Germany autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 106. Germany autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 107. UK autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 108. UK autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 109. UK autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 110. UK autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 111. UK autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 112. UK autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 113. UK autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 114. UK autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 115. UK autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 116. UK autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 117. France autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 118. France autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 119. France autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 120. France autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 121. France autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 122. France autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 123. France autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 124. France autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 125. France autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 126. France autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 127. Spain autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 128. Spain autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 129. Spain autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 130. Spain autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 131. Spain autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 132. Spain autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 133. Spain autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 134. Spain autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 135. Spain autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 136. Spain autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 137. Italy autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 138. Italy autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 139. Italy autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 140. Italy autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 141. Italy autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 142. Italy autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 143. Italy autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 144. Italy autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 145. Italy autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 146. Italy autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 147. Asia Pacific autoimmune disease diagnostics market size, by country, 2017 - 2021 (USD Million)
  • TABLE 148. Asia Pacific autoimmune disease diagnostics market size, by country, 2022 - 2030 (USD Million)
  • TABLE 149. Asia Pacific autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 150. Asia Pacific autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 151. Asia Pacific autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 152. Asia Pacific autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 153. Asia Pacific autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 154. Asia Pacific autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 155. Asia Pacific autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 156. Asia Pacific autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 157. Asia Pacific autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 158. Asia Pacific autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 159. China autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 160. China autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 161. China autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 162. China autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 163. China autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 164. China autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 165. China autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 166. China autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 167. China autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 168. China autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 169. Japan autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 170. Japan autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 171. Japan autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 172. Japan autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 173. Japan autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 174. Japan autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 175. Japan autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 176. Japan autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 177. Japan autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 178. Japan autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 179. India autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 180. India autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 181. India autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 182. India autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 183. India autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 184. India autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 185. India autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 186. India autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 187. India autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 188. India autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 189. Australia autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 190. Australia autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 191. Australia autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 192. Australia autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 193. Australia autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 194. Australia autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 195. Australia autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 196. Australia autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 197. Australia autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 198. Australia autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 199. South Korea autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 200. South Korea autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 201. South Korea autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 202. South Korea autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 203. South Korea autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 204. South Korea autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 205. South Korea autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 206. South Korea autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 207. South Korea autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 208. South Korea autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 209. Latin America autoimmune disease diagnostics market size, by country, 2017 - 2021 (USD Million)
  • TABLE 210. Latin America autoimmune disease diagnostics market size, by country, 2022 - 2030 (USD Million)
  • TABLE 211. Latin America autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 212. Latin America autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 213. Latin America autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 214. Latin America autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 215. Latin America autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 216. Latin America autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 217. Latin America autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 218. Latin America autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 219. Latin America autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 220. Latin America autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 221. Brazil autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 222. Brazil autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 223. Brazil autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 224. Brazil autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 225. Brazil autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 226. Brazil autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 227. Brazil autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 228. Brazil autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 229. Brazil autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 230. Brazil autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 231. Mexico autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 232. Mexico autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 233. Mexico autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 234. Mexico autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 235. Mexico autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 236. Mexico autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 237. Mexico autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 238. Mexico autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 239. Mexico autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 240. Mexico autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 241. Argentina autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 242. Argentina autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 243. Argentina autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 244. Argentina autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 245. Argentina autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 246. Argentina autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 247. Argentina autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 248. Argentina autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 249. Argentina autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 250. Argentina autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 251. MEA autoimmune disease diagnostics market size, by country, 2017 - 2021 (USD Million)
  • TABLE 252. MEA autoimmune disease diagnostics market size, by country, 2022 - 2030 (USD Million)
  • TABLE 253. MEA autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 254. MEA autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 255. MEA autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 256. MEA autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 257. MEA autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 258. MEA autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 259. MEA autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 260. MEA autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 261. MEA autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 262. MEA autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 263. South Africa autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 264. South Africa autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 265. South Africa autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 266. South Africa autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 267. South Africa autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 268. South Africa autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 269. South Africa autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 270. South Africa autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 271. South Africa autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 272. South Africa autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 273. Saudi Arabia autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 274. Saudi Arabia autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 275. Saudi Arabia autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 276. Saudi Arabia autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 277. Saudi Arabia autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 278. Saudi Arabia autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 279. Saudi Arabia autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 280. Saudi Arabia autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 281. Saudi Arabia autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 282. Saudi Arabia autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 283. UAE autoimmune disease diagnostics market size, by disease type, 2017 - 2021 (USD Million)
  • TABLE 284. UAE autoimmune disease diagnostics market size, by disease type, 2022 - 2030 (USD Million)
  • TABLE 285. UAE autoimmune disease diagnostics market size, by systemic autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 286. UAE autoimmune disease diagnostics market size, by systemic autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 287. UAE autoimmune disease diagnostics market size, by localized autoimmune disease, 2017 - 2021 (USD Million)
  • TABLE 288. UAE autoimmune disease diagnostics market size, by localized autoimmune disease, 2022 - 2030 (USD Million)
  • TABLE 289. UAE autoimmune disease diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 290. UAE autoimmune disease diagnostics market size, by test type, 2022 - 2030 (USD Million)
  • TABLE 291. UAE autoimmune disease diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 292. UAE autoimmune disease diagnostics market size, by end-use, 2022 - 2030 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach (supply side analysis)
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Autoimmune disease diagnostics industry 360 degree synopsis, 2017 - 2030
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry landscape 2017 - 2030 (USD Million)
  • FIG. 6 Global autoimmune disease diagnostics market size, 2017 - 2030 (USD Million)
  • FIG. 7 Growth potential analysis, by disease type
  • FIG. 8 Growth potential analysis, by test type
  • FIG. 9 Growth potential analysis, by end-use
  • FIG. 10 Porter's analysis
  • FIG. 11 Competitive matrix analysis, 2021
  • FIG. 12 PESTEL analysis
  • FIG. 13 Key segment trends, by disease type
  • FIG. 14 Key segment trends, by test type
  • FIG. 15 Key segment trends, by end-use
  • FIG. 16 Key regional trends
  • FIG. 17 Competitive dashboard, 2021
目次
Product Code: 618

The autoimmune disease diagnostics market is projected to grow massively by 2030 owing to escalating prevalence of autoimmune diseases around the world. In addition, technological advancements in the field of diagnostics and supportive government initiatives for R&D activities are speculated to impel market growth over the forecast period.

Recently, a December 2021 study published in Cells analyzed the dysregulation of the immune system caused by the COVID-19 infection, which could lead to the development of autoimmune phenomena. The research findings indicated that the coronavirus infection could precipitate systemic and rheumatic autoimmune diseases, establishing a link between the illness and new onset-rheumatic diseases to promote early diagnosis and timely therapeutic management.

Thus, the burgeoning need for diagnosing autoimmune diseases has fueled autoimmune disease diagnostics market growth considerably. Moreover, rapid advancements in autoimmune disease diagnostic systems have also stimulated business growth in the past few years.

Major companies have been focusing on strategic partnerships, mergers, collaborations, and product innovation to maintain a strong presence in the market, fostering the competitive outlook of the industry. For instance, in March 2021, Bio-Rad Laboratories, a medical device company, extended its agreement with diagnostics behemoth Roche by offering its InteliQ product range. This deal aimed to fortify the partnership between the two firms.

The autoimmune disease diagnostics market has been bifurcated in terms of end-use, test type, disease type, and region.

By disease type, the autoimmune disease diagnostics industry has been split into localized autoimmune disease and systemic autoimmune disease. The systemic autoimmune disease segment was valued at more than $327 million in 2021 attributed to the growing influence of rheumatoid arthritis, systemic lupus erythematosus (SLE), psoriasis, and so on, which has increased the need for diagnosis of these conditions.

The autoimmune disease diagnostics market has been categorized on the basis of test type into urinalysis, antinuclear antibody tests, complete blood count (CBC), autoantibody tests, c-reactive protein (CRP), and others. In 2021, the antinuclear antibody tests segment accounted for a revenue share of around 43% as a result of rising incidences of chronic ailments and diseases that target the immune systems such as type 1 diabetes, myasthenia gravis, and others.

With regards to end-use, the autoimmune disease diagnostics industry has been divided into diagnostics centers, hospitals, and others. The hospitals segment attained a valuation of over $591 million in 2021 on account of viable medical policies and surging availability of modern autoimmune diagnostics technologies that promote patient satisfaction and convenience.

In the regional landscape, the North America autoimmune disease diagnostics market is poised to grow at a CAGR of above 5.9% over the review period on account of the mounting prevalence of autoimmune diseases and growing awareness about diagnostic procedures in the region.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Base estimates & working
  • 1.4 Forecast calculations
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Autoimmune disease diagnostics industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Disease type trends
    • 2.1.3 Test type trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Autoimmune Disease Diagnostics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 High incidence and prevalence of autoimmune diseases
      • 3.3.1.2 Growing awareness about autoimmune diseases
      • 3.3.1.3 Supportive government policies for research activities on autoimmune diseases
      • 3.3.1.4 Technological advancements and increasing adoption of lab automation technologies
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Need for high capital investment in setting-up diagnosis centers
      • 3.3.2.2 Slow turnaround time for test results and need for multiple diagnostic tests
  • 3.4 Growth potential analysis
    • 3.4.1 By disease type
    • 3.4.2 By test type
    • 3.4.3 By end-use
  • 3.5 Covid-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Company matrix analysis, 2021
  • 3.8 PESTEL analysis

Chapter 4 Autoimmune Disease Diagnostics Market, By Disease Type

  • 4.1 Key segment trends
  • 4.2 Systemic Autoimmune Disease
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.2 Rheumatoid Arthritis
      • 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.3 Systemic Lupus Erythematosus
      • 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.4 Psoriasis
      • 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.5 Multiple Sclerosis
      • 4.2.5.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.6 Others
      • 4.2.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Localized Autoimmune Disease
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.3.2 Inflammatory Bowel Disease
      • 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
      • 4.3.2.2 Type 1 Diabetes
        • 4.3.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
      • 4.3.2.3 Thyroid
        • 4.3.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
      • 4.3.2.4 Others
        • 4.3.2.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Autoimmune Disease Diagnostics Market, By Test Type

  • 5.1 Key segment trends
  • 5.2 Antinuclear Antibody Tests
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Autoantibody Tests
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 C-reactive Protein (CRP)
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.5 Complete Blood Count (CBC)
    • 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.6 Urinalysis
    • 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Autoimmune Disease Diagnostics Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.3 Diagnostics Centers
    • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Autoimmune Disease Diagnostics Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017-2030 (USD Million)
    • 7.2.2 Market size, by disease type, 2017-2030 (USD Million)
      • 7.2.2.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
      • 7.2.2.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
    • 7.2.3 Market size, by test type, 2017-2030 (USD Million)
    • 7.2.4 Market size, by end-use, 2017-2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.2.5.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.2.5.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.2.5.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.2.6.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.2.6.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.2.6.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2017-2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017-2030 (USD Million)
    • 7.3.2 Market size, by disease type, 2017-2030 (USD Million)
      • 7.3.2.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
      • 7.3.2.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
    • 7.3.3 Market size, by test type, 2017-2030 (USD Million)
    • 7.3.4 Market size, by end-use, 2017-2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.3.5.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.3.5.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.3.5.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.3.6.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.3.6.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.3.6.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.3.7.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.3.7.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.3.7.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.3.8 Spain
      • 7.3.8.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.3.8.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.3.8.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.3.8.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.3.9 Italy
      • 7.3.9.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.3.9.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.3.9.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.3.9.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2017-2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017-2030 (USD Million)
    • 7.4.2 Market size, by disease type, 2017-2030 (USD Million)
      • 7.4.2.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
      • 7.4.2.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
    • 7.4.3 Market size, by test type, 2017-2030 (USD Million)
    • 7.4.4 Market size, by end-use, 2017-2030 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.4.5.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.4.5.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.4.5.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.4.6.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.4.6.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.4.6.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.4.7.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.4.7.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.4.7.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.4.8.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.4.8.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.4.8.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2017 - 2028 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.4.9.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.4.9.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.4.9.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.4.9.3 Market size, by end-use, 2017-2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017-2030 (USD Million)
    • 7.5.2 Market size, by disease type, 2017-2030 (USD Million)
      • 7.5.2.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
      • 7.5.2.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
    • 7.5.3 Market size, by test type, 2017-2030 (USD Million)
    • 7.5.4 Market size, by end-use, 2017-2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.5.5.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.5.5.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.5.5.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.5.6.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.5.6.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.5.6.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.5.7.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.5.7.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.5.7.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.5.7.3 Market size, by end-use, 2017-2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2017-2030 (USD Million)
    • 7.6.2 Market size, by disease type, 2017-2030 (USD Million)
      • 7.6.2.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
      • 7.6.2.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
    • 7.6.3 Market size, by test type, 2017-2030 (USD Million)
    • 7.6.4 Market size, by end-use, 2017-2030 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.6.5.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.6.5.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.6.5.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2017-2030 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.6.6.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.6.6.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.6.6.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size , by disease type, 2017-2030 (USD Million)
        • 7.6.7.1.1 Market size, by systemic autoimmune disease, 2017-2030 (USD Million)
        • 7.6.7.1.2 Market size, by localized autoimmune disease, 2017-2030 (USD Million)
      • 7.6.7.2 Market size, by test type, 2017-2030 (USD Million)
      • 7.6.7.3 Market size, by end-use, 2017-2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2021
  • 8.2 Abbott Laboratories
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Bio-rad Laboratories
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 F. Hoffmann-la Roche
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Thermo Fisher Scientific
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Myriad Genetics
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Euroimmun AG (Perkin Elmer)
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 DIAsource ImmunoAssays SA
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Hemagen Diagnostics
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Trinity Biotech Plc.
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 SQI Diagnostics Inc.
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Quest Diagnostics
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Siemens Healthineers Inc.
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis